Companies

Stryker corporation is a big device player with orthopaedics, spine and neuro business to name three. Yet it’s European effort continues to result in falling share and disappointment. Recent management changes haven’t yet borne fruit, but the company is expecting better times ahead. While the medtech business can be a complicated affair, we suggest basic business principles still surely apply.

The first patient has now been enrolled in the Biotronik-supported study which aims to identify risk factors that can help predict appropriateness of ICD interventions.

ConvaTec says it has entered into a definitive agreement to acquire all of the capital stock of 180 Medical Holdings, Inc. for $321 million. 180 Medical is a leading U.S. provider of disposable, intermittent catheters and urologic medical supplies.

Osseon® Therapeutics, Inc. has named Mr. Ron Clough as Chief Operating Officer. Mr. Clough has extensive experience with several companies that develop and market medical devices for the treatment of spinal disease and deformities…

This is what targeted investment in a community looks like, as Cook Medical and its parent Cook Group adds a new manufacturing facility to Canton Illinois, having already built one two years ago… and a boutique hotel! Little wonder the company feels it has the moral high ground as it fights the Government’s new medtech tax plans.

Medtronic, Inc. is announcing twin milestones for its CoreValve® clinical program on the long road to U.S. approval. First, it completed enrollment in its study of high risk patients in its U.S. Pivotal Trial, and then FDA gave it the nod to start a global trial in intermediate patients.

St.Jude has taken the radical decision to shoe-horn its previous four divisions into two. These will be called the Implantable Electronic Systems Division (IESD), which will encompass CRM and Neuromodulation, and the Cardiovascular and Ablation Technologies Division (CATD), which will encompass Atrial Fibrillation and Cardiovascular. 300 job cuts and a host of efficiency savings are anticipated.

IRIDEX Appoints Chairman William M. Moore as Interim President & CEO (via PR Newswire) MOUNTAIN VIEW, Calif., Aug. 28, 2012 … continue reading “New Interim President & CEO For Iridex”

Integra LifeSciences Holdings Corporation has announced that Thomas J. Baltimore, Jr. has resigned from its Board of Directors to focus on his role as Chief Executive Officer of RLJ Lodging Trust and to reduce his outside board commitments.

Boston Scientific’s Precisiopn Plus Spinal Cord Stimulator is now CE marked for peripheral nerve stimulation and implantees can receive MRI head-only scans, opening up diagnostic options for clinicians in Europe.

Twenty eight point reduction of systolic blood pressure after one month remained stable at three months using EnligHTN renal denervation system according to ESC hotline session data.

Covidien says its newly FDA cleared device is the world’s only fully powered reusable surgical EndoStapling platform and claims it sets new standards in precision during surgery.

Smith & Nephew has announced that the UK’s National Institute for Health and Clinical Excellence (NICE) has issued draft guidance supporting the case for utilising the Exogen Ultrasound Bone Healing System. It’s now putting its draft findings out for consultation.

Ageing population, improved screening and new treatments will drive GI Endoscopy market in U.S.A

Boston Scientific’s Watchman LAA closure device can now be used on patients not able to be given anticoagulant therapy. Also, newly revised European Society of Cardiology guidelines include LAA closure devices.

Registry data presented at ESC suggests MitraClip use is gathering pace, at least for the oldest and sickest patients for whom it is providing an alternative to surgical valve repair.